Top Stories

Chugai soars after UK says drug reduces hospital time for Covid patients


The corporate logo of Chugai Pharmaceutical Co. is displayed atop the head office of its Chugai Pharma Manufacturing Co. unit in Tokyo, Japan, on Monday, Aug. 18, 2014.

Kiyoshi Ota | Bloomberg via Getty Images

SINGAPORE — Shares of Japanese drugmaker Chugai Pharmaceutical surged on Tuesday after the U.K. government found that its drug tocilizumab was effective in reducing risk of death as well as hospitalization time for Covid patients.

By the Tuesday market close in Japan, shares of Chugai rose 5.91%. Earlier in the session, Chugai’s stock soared as much as 16.26%. Tuesday marked the first trading day of the week for Chugai as Japan’s markets were closed on Monday for a holiday.

In a


More parts of China lock down as virus cases spike ahead of WHO visit

Previous article

The majority of states aren’t following the CDC’s coronavirus vaccination distribution recommendations

Next article

You may also like

Leave a Reply

Notify of

More in Top Stories